calpeptin has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akyürek, LM; Ala, C; Alvandian, A; Bandaru, S; Devarakonda, S; Gökalp, S; Salimi, R; Yener, N | 1 |
Byler, S; Goldgar, S; Heerboth, S; Rosenthal, S; Sarkar, S | 1 |
Fernández-Muñoz, B; Martín-Villar, E; Quintanilla, M; Renart, J; Yurrita, MM | 1 |
Bae, CD; Han, BG; Kim, DS; Kim, SY; Lee, BI; Park, KS | 1 |
1 review(s) available for calpeptin and Neoplasms
Article | Year |
---|---|
Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.
Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Dipeptides; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Humans; Neoplasms | 2013 |
3 other study(ies) available for calpeptin and Neoplasms
Article | Year |
---|---|
Blocking the Cleavage of Filamin A by Calpain Inhibitor Decreases Tumor Cell Growth.
Topics: Animals; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dipeptides; Filamins; Glycoproteins; Humans; Male; Mice; Neoplasms; Proteolysis | 2018 |
Regulation of podoplanin/PA2.26 antigen expression in tumour cells. Involvement of calpain-mediated proteolysis.
Topics: Alternative Splicing; Amino Acid Sequence; Base Sequence; Calpain; Cell Line, Tumor; Dipeptides; Gene Expression; Glycoproteins; Humans; Membrane Glycoproteins; Molecular Sequence Data; Neoplasms; Protein Processing, Post-Translational; RNA, Messenger; Transcriptional Activation | 2009 |
I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Topics: Calpain; Cell Line, Tumor; Cystamine; Dipeptides; GTP-Binding Proteins; Humans; I-kappa B Proteins; Neoplasms; NF-KappaB Inhibitor alpha; Proteasome Endopeptidase Complex; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Transglutaminases; Ubiquitin | 2010 |